Johanna Seiden

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/95fdba40-848e-11ee-9baf-47fb58c10652.jpg

First Name

Johanna

Last Name

Seiden

NPI

1598260739

Faculty ID

17959

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

13539

Biography

<p>Johanna Seiden, MD, MPH, is an attending physician and Assistant Professor, Neurology at Montefiore Einstein. Dr. Seiden is specifically interested in stroke in the young, as well as stroke associated with systemic disease.</p><p>After obtaining her Bachelor of Science in biopsychology from Tufts University in 2012, Dr. Seiden earned her Doctor of Medicine and Master of Public Health at the same institution in 2018. She then came to Montefiore Einstein to continue her medical training, completing an internal medicine internship in 2019 and her residency in neurology in 2022, where she was Chief Resident in her final year. Following this, Dr. Seiden completed a fellowship in vascular neurology at New York University, in 2023.</p><p>Dr. Seiden participates in stroke disparities research both nationally and internationally. She is also interested in improving medical education in stroke. Her work has been through invited presentations and peer-reviewed publications.</p>

Is Open Scheduling

Off

Sara Shapouran

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/45450300-36e7-11ee-93c9-433c3b0369b2.jpg

First Name

Sara

Last Name

Shapouran

NPI

1902339229

Faculty ID

17617

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

157211

Is Open Scheduling

Off

Oleg Otlivanchik

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a03c2020-891b-11ec-a48a-e9e0c9e20faa.jpg

First Name

Oleg

Last Name

Otlivanchik

NPI

1659721033

Faculty ID

17323

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Vascular Neurology

Research Focus

Stroke prevention

Elsevier Profile

EMR ID

88101

Biography

<p>Oleg Otlivanchik, MD, PhD, is Co-Director, Comprehensive Stroke Center at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. Otlivanchik's clinical focus is on vascular disorders of the brain.</p><p>After obtaining his Bachelor of Science in materials science and engineering from Columbia University in 2008, Dr. Otlivanchik earned his Doctor of Philosophy in neuroscience at Rutgers University in 2014, followed by his Doctor of Medicine at the same institution in 2016. He then came to Montefiore Einstein to continue his medical training, completing his internal medicine internship in 2017, his residency in neurology in 2020 where he was Chief Resident in his final year, and a fellowship in vascular neurology in 2021.</p><p>Dr. Otlivanchik's research interests include quality improvement, stroke education, diagnostic error, atherosclerotic disease, stroke prevention and neurorehabilitation. He has been the site primary investigator and research assistant on several research projects, and his work has been published in numerous peer-reviewed journals, review articles and abstracts.</p><p>Dr. Otlivanchik is a Diplomate of the American Board of Psychiatry and Neurology and is a member of the American Academy of Neurology.</p>

Is Open Scheduling

Off

Peter C. Mabie

https://assets.montefioreeinstein.org/profiles/images/835-peter-mabie.jpg

First Name

Peter

Last Name

Mabie

NPI

1316022635

Faculty ID

835

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

PubMed.gov URL

EMR ID

3833

Is Open Scheduling

Off

Daniel L. Labovitz

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/6d08f9d0-c6d2-11ed-9d89-7db087ef8bda.jpg

First Name

Daniel

Last Name

Labovitz

NPI

1053398560

Faculty ID

12050

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Labovitz is&nbsp;a&nbsp;board-certified vascular neurologist&nbsp;and neuroepidemiologist and is director of the Stern Stroke Center.&nbsp;He completed his residency, fellowship and epidemiology training at Columbia University.&nbsp;Recent&nbsp;projects have used the Montefiore Stroke Registry for publications on imaging of intracerebral hemorrhage and diagnosis of transient ischemic attack.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<iframe allowfullscreen="" frameborder="0" height="281" src="//www.youtube.com/embed/FjyhLMYO7Cs?rel=0&quot; width="500"></iframe>

Elsevier Profile

PubMed.gov URL

Lab Website Link

Selected Publications

<h3><strong>Original Peer-reviewed Reports</strong></h3>
<p>Springer, M, Labovitz DL. The capsular warning syndrome reconsidered. Cerebrovasc Dis 2013<span>;36:152.</span></p>
<p>Fields MC, Labovitz DL, French JA.&nbsp; Hospital onset seizures&mdash;an inpatient study.&nbsp; JAMA Neurol 2013 Mar 1;70:360-364. doi: 10.1001/2013.jamaneurol.337.</p>
<p>Liff JM, Labovitz D, Robbins MS. Profound gastroparesis after bilateral posterior inferior cerebellar artery territory infarcts. Clin Neurol Neurosurg. 2012:789-91. doi: 10.1016/j.clineuro.2011.12.042.</p>
<p>Bunch ME, Nunziato EC, Labovitz DL. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes. J Stroke Cerebrovasc Dis 2012:808-11. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.012.</p>
<p>Labovitz DL, Boden-Albala B, Hauser WA, Sacco RL.&nbsp; Lacunar infarct or deep intracerebral hemorrhage: who gets which?&nbsp; The Northern Manhattan Study. Neurology 2007;68:606-608.</p>
<p>Boylan LS, Labovitz DL, Jackson SC, Starner K, Devinsky, O.&nbsp; Auras are frequent in idiopathic generalized epilepsy. Neurology 2006;67:343-345.</p>
<p>Labovitz DL, Halim AX, Brent B, Boden-Albala B, Hauser WA, Sacco RL.&nbsp; Subarachnoid hemorrhage incidence among whites, blacks and Caribbean Hispanics: The Northern Manhattan Study. Neuroepidemiology 2006;26:147-150.</p>
<p>Labovitz DL, Halim A, Boden-Albala B, Hauser WA, Sacco RL.&nbsp; The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 2005;65:518-522.</p>
<p>Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004;62:258-261.</p>
<p>Stapf C, Labovitz DL, Sciacca RR, Mast H, Mohr JP, Sacco RL. Incidence of adult brain AVM hemorrhage in a prospective population-based stroke survey. Cerebrovasc Dis 2002;13:43-46.</p>
<p>Labovitz DL, Hauser WA, Sacco RL.&nbsp;&nbsp; Prevalence and predictors of early seizure and status epilepticus after first stroke: the Northern Manhattan Stroke Study. Neurology 2001;57:200-206.</p>
<p>Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, Gormanz JM. Schizophrenia after prenatal famine: further evidence. Arch Gen Psych 1996;53:25-31.</p>
<h3><strong>Reviews, Editorials, and Letters</strong></h3>
<p>Bhupali DP, Labovitz DL. Clinical Scores for Predicting Recurrence After Transient Ischemic Attack or Stroke, How Good are They? Stroke 2013; in press. (letter)</p>
<p>Labovitz DL, Bhupali DP.&nbsp; Transient ischemic attack in Joinville, Brazil, 2010: a population-based study. Stroke 2012; doi: 10.1161/strokeaha.112.651356. (letter)</p>
<p>Labovitz DL. Keeping an eye on lacunar infarction. Stroke 2010;41:1314-1315. (editorial)</p>
<p>Labovitz D. Uncommon causes of stroke. Neurology 2010;75:1661. (editorial)</p>
<p>Al-Shahi SR, Labovitz DL, Stapf C. Spontaneous intracerebral haemorrhage. BMJ 2009; 339:b2586. (review)</p>
<p>Labovitz DL. Accuracy and yield of ICD-9 codes for identifying children with ischemic stroke.&nbsp; Neurology 2007;68:1638. (letter)</p>
<p>Boylan LS, Labovitz DL. Unbalanced statistical analysis of combined divalproex <br /> and antipsychotic therapy for schizophrenia. Neuropsychopharmacology 2004;29:636. (letter)</p>
<p>Tebartz van Elst L, Trimble MR, Boylan LS, Labovitz DL, Flint LA, Devinsky O.&nbsp; Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.&nbsp; Neurology 2004;64:942-943. (letter)</p>
<p>Labovitz DL, Hauser WA. Preventing stroke-related seizures: when should antiepileptic drugs be started? Neurology 2003;60:365-366. (editorial)</p>
<p>Labovitz DL, Sacco RL. Intracerebral hemorrhage: update. Curr Opin Neurol 2001;14:103-108. (review)</p>

EMR ID

5237

Biography

<p>Daniel Lockett Labovitz, MD, MS, is Medical Director, Montefiore Comprehensive Center for Stroke Care and Associate Professor, Neurology at our Albert Einstein College of Medicine. Dr. Labovitz is a vascular neurologist with a clinical focus solely on stroke diagnosis, prevention and management. In his role at the Montefiore Comprehensive Center for Stroke Care, he has a particular focus on fostering interdisciplinary collaboration to better serve stroke patients.</p><p>In 1987, Dr. Labovitz received his Bachelor of Arts magna cum laude from Harvard University. He went on to attend Columbia University College of Physicians and Surgeons, earning his Doctor of Medicine in 1994. His postdoctoral training began with an internship in medicine at Saint Vincent&rsquo;s Hospital. He then attended the Neurological Institute, completing a three-year residency in neurology in 1998 and a two-year clinical and research fellowship in stroke and neuroepidemiology in 2000. In 2001, he received his Master of Science in epidemiology from Columbia University Mailman School of Public Health.</p><p>Dr. Labovitz&rsquo;s research focuses on intracerebral hemorrhage and stroke-related epilepsy. He has produced and published many original peer-reviewed reports and is an ad hoc reviewer on several journals, including Neurology, Stroke and the Journal of Stroke and Cerebrovascular Diseases.</p><p>Dr. Labovitz is a member of the American Academy of Neurology as well as the Stroke Council of the American Stroke Association.</p>

Is Open Scheduling

Off

Kathryn F. Kirchoff-Torres

https://assets.montefioreeinstein.org/profiles/images/physphoto/Kirchoff_Kathyn_MD.jpg

First Name

Kathryn

Last Name

Kirchoff-Torres

NPI

1326201245

Faculty ID

12222

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Kirchoff-Torres joined the neurology faculty in 2010 after completing her training in neurology and vascular neurology at the Mount Sinai School of Medicine.&nbsp; She is board certified in neurology and vascular neurology by the American Board of Psychiatry and Neurology, and in Neurovascular Interpretation of carotid and transcranial ultrasound by the American Society of Neuroimaging.&nbsp; He interests include acute ischemic stroke, intracerebral hemorrhage, vascular malformations of the central nervous system, cerebrovascular disorders of pregnancy, hypercoagulable disorders and stroke education.&nbsp; She is an attending neurologist at Montefiore Medical Center and sees outpatients at the Stern Stroke Center.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Kirchoff-Torres&rsquo; clinical interests are in emergency care and acute management of cerebrovascular disorders, including ischemic stroke, intracerebral hemorrhage and vascular malformations, as well as the treatment of post-stroke patients to prevent recurrent stroke.

Research Focus

Dr. Kirchoff-Torres&rsquo; particular research interests are in hematological disorders and cerebrovascular disease, pregnancy-related cerebrovascular disease, cerebral hyperperfusion syndrome after carotid revascularization and cardioembolic stroke. Her research has been published in reviewed publications, and she has produced many abstracts and posters.

Elsevier Profile

PubMed.gov URL

Selected Publications

<p>Baffour FI, <strong>Kirchoff-Torres KF</strong>, Einstein FH, Karakash S, Miller TS. Bilateral internal carotid artery dissection in the postpartum period.Obstetrics &amp; Gynecology 2012 Feb;119(Part 2):489-492.</p>
<p>Zach V, Zhovtis S, <strong>Kirchoff-Torres KF</strong>, Weinberger JM. Common carotid artery dissection: a case report and review of the literature. Journal of Stroke &amp; Cerebrovascular Diseases 2012 Jan;21(1):52-60.</p>
<p>Goulart JM, Yoo JY, <strong>Kirchoff-Torres KF</strong>, Delman BN, Tuhrim S. Ischemic stroke in an adult with Glycogen Storage Disease Type I. J Clin Neurosci 2010 Nov;17(11):1467-9.</p>
<p>Katz M, Lesko J, <strong>Kirchoff-Torres KF</strong>, Zach V, Levine SR. Cerebrovascular disease and pregnancy. Fetal and Maternal Medicine Review 2010; 21:2 114&ndash;162.</p>
<p><strong>Kirchoff-Torres K</strong>, Levine SR. Antiphospholipid antibodies: pinning risk on a moving target. Lancet Neurology 2009;8(11):971-3.</p>
<p><strong>Kirchoff KF.</strong> Travelogue. Contexts: A Forum for Medical Humanities. 2001;9(4):5-7.</p>

EMR ID

5374

Biography

<p>Kathryn F. Kirchoff-Torres, MD, is Attending Neurologist at Montefiore and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. Kirchoff-Torres&rsquo; clinical interests are in emergency care and acute management of cerebrovascular disorders, including ischemic stroke, intracerebral hemorrhage and vascular malformations, as well as the treatment of post-stroke patients to prevent recurrent stroke.</p><p>After receiving her Bachelor of Science in neuroscience from the University of Rochester in 1999, Dr. Kirchoff-Torres attended SUNY Stony Brook School of Medicine, receiving her Doctor of Medicine in 2004. She pursued her postgraduate training at Mount Sinai School of Medicine, completing an internship in internal medicine in 2005, a residency in neurology in 2008, a clinical fellowship in vascular neurology in 2009 and a clinical and postdoctoral fellowship in vascular neurology in 2010.</p><p>Dr. Kirchoff-Torres&rsquo; particular research interests are in hematological disorders and cerebrovascular disease, pregnancy-related cerebrovascular disease, cerebral hyperperfusion syndrome after carotid revascularization and cardioembolic stroke. Her research has been published in reviewed publications, and she has produced many abstracts and posters. She is also an ad hoc reviewer for several publications, including the <em>American Journal of Neuroradiology</em>, the <em>Journal of Neurology, Neurosurgery &amp; Psychiatry</em> and the <em>Journal of Experimental Stroke &amp; Translational Medicine</em>.</p><p>Dr. Kirchoff-Torres has been listed in Castle Connolly Top Doctors for several years. She is board certified in neurology and vascular neurology.</p>

Is Open Scheduling

Off

Charles C. Esenwa

https://assets.montefioreeinstein.org/profiles/images/Esenwa_Charles_MD_2x.jpg

First Name

Charles

Last Name

Esenwa

NPI

1245556901

Faculty ID

15684

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Charles Esenwa is an Assistant Professor of Neurology at Albert Einstein College of Medicine and clinical stroke neurologist at Montefiore Medical Center. Dr. Esenwa attended medical school at SUNY Downstate College of Medicine, and completed a residency in Neurology at the Neurological Institute of New York, where he also served as chief resident and a fellow in vascular neurology. While at Columbia, he completed formal training in neuroepidemiology under an NIH T32 grant.<br />He is dedicated to humanistic patient care and is the recipient of the Arnold P. Gold Humanism in Medicine Award, and the Neurological Institute&rsquo;s Daniel Sciarra patient care and humanism award. He has published on acute stroke management, stroke risk factors, secondary stroke prevention and stroke disparities, and is interested in advancing health care delivery to populations on the local, national and international levels.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Esenwa specializes in acute stroke care and stroke prevention in high-risk communities.&nbsp; He is the medical director of the Montefiore Comprehensive Center for Stroke Care.

Elsevier Profile

Selected Publications

<p class="MsoListParagraph" style="mso-add-space: auto; line-height: normal; mso-outline-level: 1; background: white; margin: 12.0pt 0in 6.0pt 0in;"><span style="font-family: 'Verdana',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; color: black; mso-color-alt: windowtext; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Journal Publications</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa C</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">, Cheng NT, Lipsitz E, Hsu K, Zampolin R, Gersten A, Antoniello D, Soetanto A, Kirchoff K, Liberman A, Mabie P, Nisar T, Rahimian D, Brook A, Lee SK, Haranhalli N, Altschul D, Labovitz D. <em>COVID-19-Associated Carotid Atherothrombosis and Stroke.</em> AJNR Am J Neuroradiol. 2020 Aug 20. doi: 10.3174/ajnr.A6752.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa C,</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;"> Parides MK, Labovitz DL. <em>The effect of COVID-19 on stroke hospitalizations in New York City</em>. J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105114. doi: 10.1016/j.jstrokecerebrovasdis.2020.105114. Epub 2020 Jul 13.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Altschul DJ, <strong>Esenwa C</strong>, Haranhalli N, Unda SR, de La Garza Ramos R, Dardick J, Fernandez-Torres J, Toma A, Labovitz D, Cheng N, Lee SK, Brook A, Zampolin R. <em>Predictors of mortality for patients with COVID-19 and large vessel occlusion</em>. Interv Neuroradiol. 2020 Oct;26(5):623-628. doi: 10.1177/1591019920954603. Epub 2020 Aug 30. PMID: 32862753.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Liberman AL, Wang C, Friedman BW, Prabhakaran S, <strong>Esenwa CC</strong>, Rostanski SK, Cheng NT, Erdfarb A, Labovitz DL, Lipton RB. <em>Head Computed tomography during emergency department treat-and-release visit for headache is associated with increased risk of subsequent cerebrovascular disease hospitalization</em>. Diagnosis (Berl). 2020 Oct 5:/j/dx.ahead-of-print/dx-2020-0082/dx-2020-0082.xml. </span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">McHugh DC<strong>, Esenwa C</strong>. A Novel COL4A2 <em>Mutation Associated with Recurrent Strokes</em>. J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105156. doi:</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Altschul DJ, Haranhalli N, <strong>Esenwa C</strong>, Unda SR, de La Garza Ramos R, Dardick J, Fernandez-Torres J, Toma A, Labovitz D, Cheng N, Lee SK, Brook A, Zampolin R. <em>The Impact of COVID-19 on Emergent Large-Vessel Occlusion: Delayed Presentation Confirmed by ASPECTS.</em> AJNR Am J Neuroradiol. 2020 Sep 3. doi: 10.3174/ajnr.A6800.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Liberman AL, Navi BB, <strong>Esenwa</strong> CC, Zhang C, Song J, Cheng NT, Labovitz DL, Kamel H, Merkler AE. <em>Misdiagnosis of Cervicocephalic Artery Dissection in the Emergency Department.</em></span></p>
<p class="details" style="margin: 0in 0in 0in .5in;"><span class="jrnl"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Stroke</span></span><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">. 2020 Apr 16:STROKEAHA120029390. doi: 10.1161/STROKEAHA.</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">, C. et al<em>. Racial Differences in Mechanical Thrombectomy Utilization for Ischemic Stroke in the United States</em>. Ethn Dis 30, 91-96 (2020).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Liberman, A. L., Bakradze, E., McHugh, D. C., </span><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa, </span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">C. C. &amp; Lipton, R. B. <em>Assessing diagnostic error in cerebral venous thrombosis via detailed chart review.</em> Diagnosis (Berl) 6 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa,</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;"> C., Labovitz, D. &amp; Caplan, L. R. "Basilar Web" Causing Basilar Branch Infarction. J Stroke Cerebrovasc Dis 28, 104366 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Dardick, </span><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa, C</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">., et al. <em>Acute Lateral Medullary Infarct due to Giant Cell Arteritis: A Case Study</em>. Stroke 50, e290-e293 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Bakradze E, Kirchoff KF, Antoniello D, Springer MV, Mabie PC, </span><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa CC,</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;"> Labovitz DL, Liberman AL.<em>Varicella Zoster Virus Vasculitis and Adult Cerebrovascular Disease</em>. Neurohospitalist 9, 203-208 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">Esenwa, C</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">., Tshiswaka, DL., Gebregziabher, M., Ovbiagele, B. <em style="mso-bidi-font-style: normal;"><span style="mso-bidi-font-weight: bold;">Historical Slavery and Modern-Day Stroke Mortality in the United States Stroke Belt</span></em><span style="mso-bidi-font-weight: bold;">.<em> Stroke</em>. 2018 (in press)</span></span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Boehme, A., <strong>Esenwa</strong>, C., Elkind, M.S. </span><em style="mso-bidi-font-style: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Stroke Risk Factors, Genetics, and Prevention.</span></em><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;"> Circulation Research. 120, 3 (2017)</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C.C. &amp; Elkind, M.S. <em style="mso-bidi-font-style: normal;">Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke</em>. Nat Rev Neurol 12, 594-604 (2016).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C. &amp; Gutierrez, J. <em style="mso-bidi-font-style: normal;">Secondary stroke prevention: challenges and solutions</em>. Vasc Health Risk Manag 11, 437-50 (2015).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C.C. &amp; Elkind, M.S<em style="mso-bidi-font-style: normal;">. A questionable cause of intracerebral hemorrhage.</em> JAMA Neurol 70, 653-4 (2013).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">Kummer B, Kerner B,<strong style="mso-bidi-font-weight: normal;"> Esenwa C. </strong><em style="mso-bidi-font-style: normal;">Voltage Gated Potassium Channel Antibody Encephalitis Associated with Hyperglycemia</em>. J Clin Case Rep. 2014 Dec. 4:464</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C.C. &amp; Leaf, D.E. <em style="mso-bidi-font-style: normal;">Colpocephaly in adults.</em> BMJ Case Rep 2013 (2013).</span></p>
<p class="MsoNormal">&nbsp;</p>
<p class="MsoNormal"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">Book Publications </span></p>
<ul style="margin-top: 0in;" type="disc">
<li class="MsoNormal" style="mso-list: l0 level1 lfo1; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa C</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Czeisler B, Mayer S. 2015<em style="mso-bidi-font-style: normal;">. Chapter 35</em>, <em style="mso-bidi-font-style: normal;">Acute Ischemic Stroke</em>.</span><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;"> In E. Louis, S. Mayer and L. Rowland</span><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Merritt&rsquo;s Neurology Thirteenth Ed. Philadelphia, PA: Walters Kluwer.</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo1; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa C</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Elkind M. 2015. <em style="mso-bidi-font-style: normal;">Chapter 44, </em></span><em style="mso-bidi-font-style: normal;"><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;">Primary and Secondary Stroke Prevention</span></em><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;">. In E. Louis, S. Mayer and L. Rowland</span><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Merritt&rsquo;s Neurology Thirteenth Ed. Philadelphia, PA: Walters Kluwer.</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo1; text-autospace: ideograph-numeric ideograph-other;"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Rinaldi A, <strong>Esenwa C.</strong> 2015. <em style="mso-bidi-font-style: normal;">Chapter 121, Gastric and Genitourinary Function and the Brain</em></span><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;">.<span style="mso-spacerun: yes;">&nbsp; </span>In E. Louis, S. Mayer and L. Rowland</span><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Merritt&rsquo;s Neurology Thirteenth Ed. Philadelphia, PA: Walters Kluwer.</span></li>
</ul>
<p class="MsoNormal" style="margin-bottom: 6.0pt; mso-outline-level: 1; background: white;">&nbsp;</p>
<p class="MsoNormal" style="margin-bottom: 6.0pt; mso-outline-level: 1; background: white;"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Abstracts:</span></p>
<ul type="disc">
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Esenwa et al</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">.&nbsp;<em>Identifying acute ischemic stroke by analyzing ICD-10 claims data using machine learning models. International Stroke Conference 2017 meeting.</em></span></li>
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Esenwa et al</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">.&nbsp;<em>Identifying stroke subtypes with high accuracy using machine learning and ICD-9 claims data</em>. International Stroke Conference 2017 meeting.</span></li>
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Esenwa et al</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">.&nbsp;<em>T1 Rho Magnetic Resonance (MR) imaging can quantify acute cerebrovascular infarct in humans and is stable in the subacute period.&nbsp;</em>International Stroke Conference 2017 meeting.</span></li>
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Soun J &amp;&nbsp;<strong>Esenwa&nbsp;</strong>C. Quantitative T1 Rho MR imaging of Acute Ischemic Infarct. ASNR meeting April, 2016 Poster</span></li>
</ul>

EMR ID

6493

Biography

<p>Charles C. Esenwa, MD, MS, is a Director at Montefiore&rsquo;s Center for Comprehensive Stroke and Assistant Professor at our Albert Einstein College of Medicine. He specializes in vascular neurology, with a particular interest in acute stroke management and stroke prevention strategies in high-risk individuals.</p><p>After receiving his Bachelor of Science in microbiology from Penn State University in 2006, Dr. Esenwa attended SUNY Downstate Medical Center, earning his medical degree in 2010. He pursued his postdoctoral training at NewYork-Presbyterian Hospital, completing a medical internship in 2011 and a residency in the department of neurology in 2014. He was invited to complete an additional year, serving as chief resident for the department of neurology. From 2015 to 2017, he continued at the institution as a vascular neurology clinical and neuroepidemiology postdoctoral fellow. In 2017, he earned his Master of Science in neuroepidemiology from Columbia University Mailman School of Public Health.</p><p>Dr. Esenwa&rsquo;s research focus is on acute stroke management, stroke risk factors and stroke prevention. His research has been published in several reviewed journals, books and abstracts.</p><p>Dr. Esenwa is the recipient of the 2010 Leonard Tow Humanism in Medicine Award from the Arnold P. Gold Foundation and the 2014 Columbia University Department of Neurology Daniel Sciarra Award for patient care and humanism. He was selected to participate in the American Academy of Neurology&rsquo;s Emerging Leaders Program in 2018-2019. Dr. Esenwa is an active board member of the New York State Neurological Society, and he is a member of the American Heart Association and the American Academy of Neurology.</p>

Is Open Scheduling

Off

Daniel Antoniello

https://assets.montefioreeinstein.org/profiles/images/physphoto/Antoniello_Daniel_MD_420x504.jpg

First Name

Daniel

Last Name

Antoniello

NPI

1790851467

Faculty ID

11330

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Antoniello is a board-certified vascular neurologist and behavioral neurologist. He is director of the vascular neurology training fellowship. He completed his vascular neurology training at Columbia University, and cognitive neurology at the University of Florida. He completed his neurology training at Montefiore Hospital/Albert Einstein College of Medicine. Dr. Antoniello specializes in the clinical care of stroke patients and disorders of cognition. His research interest concentrates on the overlap between stroke and cognition.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p><strong>Antoniello D</strong>, Patel NR, Ladsaria SS. Three-Dimensional Vascular Maps of the Anterior Choroidal Artery Territory. Stroke 2023</p>
<p><strong>Antoniello D</strong>, Fernandez-Torres J. Three-Dimensional Vascular Maps of the Thalamus. Stroke 2023.</p>
<p>Nelson EA, Ghosh D, Pineda DM, <strong>Antoniello D</strong>. Auditory Hallucinations Associated With an Arteriovenous Malformation of the Brain. J Neuropsychiatry Clin Neurosci. 2022 Winter;34(1):89-92.</p>
<p><strong>Antoniello D</strong>, Milstein MJ, Dardick J, Fernandez-Torres J, Lu J, Patel, Esenwa C. Altered mental status in COVID-19. J Neurol 2022 Jan;269(1):12-18.</p>
<p><strong>Antonello D</strong>, Gottesmen R. The phenomenology of anosognosia for hemiplegia. J Neuropsychiatry Clin Neurosci. 2019. Summer; 32(3):259-265.</p>
<p><strong>Antoniello D</strong>, Gottessman R. Limb Misidentification: A Clinical-Anatomical Prospective Study.&nbsp; J Neuropsychiatry Clin Neurosci. 2017 Summer;29 (3): 284-288</p>
<p>Jablonski K, <strong>Antoniello</strong>. Teaching video neuroimages: callosal apraxia: a straightforward model of ideomotor apraxia. Neurology. 2013 May 28;80 (22):e239<br /><br /><strong>Antoniello D</strong>, Kluger BM, Sahlein DH, Heilman KM.&nbsp; Phantom limb after stroke: an underreported phenomenon.&nbsp; Cortex, 2009 Oct Epub.<br /><br />Lazar RM, <strong>Antoniello D</strong>. Variability in recovery from aphasia. Curr Neurol Neurosci Rep. 2008 Nov;8(6):497-5</p>
<!--

<p>Antonello D, Gottesmen. The phenomenology of anosognosia for hemiplegia. J Neuropsychiatry Clin Neurosci. 2019. Summer (in press)</p>
<p>Antoniello D, Gottessman R. Limb Misidentification: A Clinical-Anatomical Prospective Study.&nbsp; J Neuropsychiatry Clin Neurosci. 2017 Summer;29 (3): 284-288</p>
<p>Jablonski K, Antoniello. Teaching video neuroimages: callosal apraxia: a straightforward model of ideomotor apraxia. Neurology. 2013 May 28;80 (22):e239<br /><br />Antoniello D, Kluger BM, Sahlein DH, Heilman KM.&nbsp; Phantom limb after stroke: an underreported phenomenon.&nbsp; Cortex, 2009 Oct Epub.<br /><br />Lazar RM, Antoniello D. Variability in recovery from aphasia. Curr Neurol Neurosci Rep. 2008 Nov;8(6):497-5</p>

-->

EMR ID

4548

Is Open Scheduling

Off